Saad F - Search Results

1

Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma. Canadian Urologic Oncology Group.

Gleave ME, Elhilali M, Fradet Y, Davis I, Venner P, Saad F, Klotz LH, Moore MJ, Paton V, Bajamonde A. Gleave ME, et al. Among authors: saad f. N Engl J Med. 1998 Apr 30;338(18):1265-71. doi: 10.1056/NEJM199804303381804. N Engl J Med. 1998. PMID: 9562580 Free article. Clinical Trial.

2

Placebo-associated remissions in a multicentre, randomized, double-blind trial of interferon gamma-1b for the treatment of metastatic renal cell carcinoma. The Canadian Urologic Oncology Group.

Elhilali MM, Gleave M, Fradet Y, Davis I, Venner P, Saad F, Klotz L, Moore R, Ernst S, Paton V. Elhilali MM, et al. Among authors: saad f. BJU Int. 2000 Oct;86(6):613-8. doi: 10.1046/j.1464-410x.2000.00880.x. BJU Int. 2000. PMID: 11069364 Clinical Trial.

3

Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy: biochemical and pathological effects.

Gleave ME, Goldenberg SL, Chin JL, Warner J, Saad F, Klotz LH, Jewett M, Kassabian V, Chetner M, Dupont C, Van Rensselaer S; Canadian Uro-Oncology Group. Gleave ME, et al. Among authors: saad f. J Urol. 2001 Aug;166(2):500-6; discussion 506-7. J Urol. 2001. PMID: 11458055 Clinical Trial.

4

Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer.

Saad F, Gleason DM, Murray R, Tchekmedyian S, Venner P, Lacombe L, Chin JL, Vinholes JJ, Goas JA, Zheng M; Zoledronic Acid Prostate Cancer Study Group. Saad F, et al. J Natl Cancer Inst. 2004 Jun 2;96(11):879-82. doi: 10.1093/jnci/djh141. J Natl Cancer Inst. 2004. PMID: 15173273 Clinical Trial.

5

Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study.

Lessard L, Bégin LR, Gleave ME, Mes-Masson AM, Saad F. Lessard L, et al. Among authors: saad f. Br J Cancer. 2005 Oct 31;93(9):1019-23. doi: 10.1038/sj.bjc.6602796. Br J Cancer. 2005. PMID: 16205698 Free PMC article.

6

Expression and nuclear localization of ErbB3 in prostate cancer.

Koumakpayi IH, Diallo JS, Le Page C, Lessard L, Gleave M, Bégin LR, Mes-Masson AM, Saad F. Koumakpayi IH, et al. Among authors: saad f. Clin Cancer Res. 2006 May 1;12(9):2730-7. doi: 10.1158/1078-0432.CCR-05-2242. Clin Cancer Res. 2006. PMID: 16675564

7

Defining the optimal treatment strategy for localized prostate cancer patients: a survey of ongoing studies at the National Cancer Institute of Canada Clinical Trials Group.

Parulekar WR, McKenzie M, Chi KN, Klotz L, Catton C, Brundage M, Ding K, Hiltz A, Meyer R, Saad F. Parulekar WR, et al. Among authors: saad f. Curr Oncol. 2008 Aug;15(4):179-84. doi: 10.3747/co.v15i4.257. Curr Oncol. 2008. PMID: 18769611 Free PMC article.

8

A phase 2 study of patupilone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: Canadian Urologic Oncology Group study P07a.

Chi KN, Beardsley E, Eigl BJ, Venner P, Hotte SJ, Winquist E, Ko YJ, Sridhar SS, Weber D, Saad F. Chi KN, et al. Among authors: saad f. Ann Oncol. 2012 Jan;23(1):53-58. doi: 10.1093/annonc/mdr336. Epub 2011 Jul 16. Ann Oncol. 2012. PMID: 21765178 Free article. Clinical Trial.

9

Progression-free survival as a clinical trial endpoint in advanced renal cell carcinoma.

Hotte SJ, Bjarnason GA, Heng DY, Jewett MA, Kapoor A, Kollmannsberger C, Maroun J, Mayhew LA, North S, Reaume MN, Ruether JD, Soulieres D, Venner PM, Winquist EW, Wood L, Yong JH, Saad F. Hotte SJ, et al. Among authors: saad f. Curr Oncol. 2011 Oct;18 Suppl 2(Suppl 2):S11-9. Curr Oncol. 2011. PMID: 21969807 Free PMC article.

10

A phase 3, double-blind, randomised, parallel-group, placebo-controlled study of oral weekly alendronate for the prevention of androgen deprivation bone loss in nonmetastatic prostate cancer: the Cancer and Osteoporosis Research with Alendronate and Leuprolide (CORAL) study.

Klotz LH, McNeill IY, Kebabdjian M, Zhang L, Chin JL; Canadian Urology Research Consortium. Klotz LH, et al. Eur Urol. 2013 May;63(5):927-35. doi: 10.1016/j.eururo.2012.09.007. Epub 2012 Sep 11. Eur Urol. 2013. PMID: 23040208 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,350 results

Search Page